Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
UMKC joins campus network’s student Entrepreneur Quest accelerator competition
A final showdown of student startups has been set, as budding entrepreneurs from across the University of Missouri campus network compete for financial support. “It brings a lot of those best practices together from all four campuses and really showcases all the great work that’s going on in the system to promote entrepreneurship,” said Andy…
Mom-and-popping it: Nounou platform curates trusted babysitters for JoCo families
Nounou Neighbors takes the fear out of the surprisingly cutthroat babysitting industry, said Molly Smalley, noting her online platform raised 200 percent client base growth in 2018. “As a mom, finding [a babysitter] is exhausting and friends never want to give you their sitter,” laughed Molly, founder of the Kansas-based babysitting service with her husband,…
Doob in doubt: 3D-printed action figures fighting to secure a paying audience in KC
Business isn’t what it should be for a company as innovative as Doob 3D, Nick Nikkhah said openly, seated on a leather couch that looked out across the Overland Park retail store’s showroom. “People don’t know what to do with [Doob]. They’re just like, ‘Whoa, what is that?’ … It’s a new thing for me.…
Reports: St. Louis startup scene surging while KC struggles to keep pace with past wins
Founders hoping to launch a new startup or move into a fresh market might have better success in St. Louis, rather than Kansas City, according to Inc. magazine’s Surge Cities Index. Inc. placed St. Louis at No. 33 on its 50 Best Places in America for Starting a Business list. Kansas City was positioned at…